Implementation of a Clinical Prediction Model Using Daily Postnatal Weight Gain, Birth Weight, and Gestational Age to Risk Stratify ROP

Retinopathy of prematurity (ROP) is a disease of the developing retinal vasculature of preterm infants and a significant treatable cause of blindness in children.1 –4 With timely detection, ROP is often treatable with laser ablation treatment and, in some cases, anti-vascular endothelial growth factor antibody intravitreal bevacizumab injections.5–7 Given the high risk of ROP and improvement in outcomes with early treatment, screening for ROP has been wide ly adopted as a mainstay of neonatal care. Current ROP screening guidelines are based on a simple clinical prediction model consisting of two

Source: Journal of Pediatric Ophthalmology and Strabismus - June 19, 2018 Category: Opthalmology Authors: Kortany McCauley, MD Source Type: research